Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.

Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL.

Front Immunol. 2014 Oct 20;5:429. doi: 10.3389/fimmu.2014.00429. eCollection 2014. Review.

2.

Integrating public health education in a public health practice setting: the experience of the School of Public Health, University at Albany and the New York State Department of Health.

Birkhead GS, Eidson M, Dewar D, Nasca P, Morse DL, Shah NR.

J Public Health Manag Pract. 2014 May-Jun;20(3):278-84. doi: 10.1097/PHH.0b013e31829a4d73.

PMID:
24667187
3.

Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy.

Foroutan P, Kreahling JM, Morse DL, Grove O, Lloyd MC, Reed D, Raghavan M, Altiok S, Martinez GV, Gillies RJ.

PLoS One. 2013 Dec 16;8(12):e82875. doi: 10.1371/journal.pone.0082875. eCollection 2013.

4.

Rapid screening of novel agents for combination therapy in sarcomas.

Cubitt CL, Menth J, Dawson J, Martinez GV, Foroutan P, Morse DL, Bui MM, Letson GD, Sullivan DM, Reed DR.

Sarcoma. 2013;2013:365723. doi: 10.1155/2013/365723. Epub 2013 Oct 24.

5.

Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Tafreshi NK, Lloyd MC, Bui MM, Gillies RJ, Morse DL.

Subcell Biochem. 2014;75:221-54. doi: 10.1007/978-94-007-7359-2_12. Review.

6.

Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

Alleti R, Vagner J, Dehigaspitiya DC, Moberg VE, Elshan NG, Tafreshi NK, Brabez N, Weber CS, Lynch RM, Hruby VJ, Gillies RJ, Morse DL, Mash EA.

Bioorg Med Chem. 2013 Sep 1;21(17):5029-38. doi: 10.1016/j.bmc.2013.06.052. Epub 2013 Jul 2.

7.

Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor.

Barkey NM, Preihs C, Cornnell HH, Martinez G, Carie A, Vagner J, Xu L, Lloyd MC, Lynch VM, Hruby VJ, Sessler JL, Sill KN, Gillies RJ, Morse DL.

J Med Chem. 2013 Aug 22;56(16):6330-8. doi: 10.1021/jm4005576. Epub 2013 Aug 9.

8.

In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Tafreshi NK, Silva A, Estrella VC, McCardle TW, Chen T, Jeune-Smith Y, Lloyd MC, Enkemann SA, Smalley KS, Sondak VK, Vagner J, Morse DL.

Mol Pharm. 2013 Aug 5;10(8):3175-85. doi: 10.1021/mp400222j. Epub 2013 Jul 8.

9.

Molecular imaging of breast cancer lymph node metastasis.

Tafreshi NK, Gillies RJ, Morse DL.

Eur J Radiol. 2012 Sep;81 Suppl 1:S160-1. doi: 10.1016/S0720-048X(12)70067-0. No abstract available.

PMID:
23083574
10.

The role of tumor tissue architecture in treatment penetration and efficacy: an integrative study.

Rejniak KA, Estrella V, Chen T, Cohen AS, Lloyd MC, Morse DL.

Front Oncol. 2013 May 10;3:111. doi: 10.3389/fonc.2013.00111. eCollection 2013.

11.

Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract.

Martinez GV, Navath S, Sewda K, Rao V, Foroutan P, Alleti R, Moberg VE, Ahad AM, Coppola D, Lloyd MC, Gillies RJ, Morse DL, Mash EA.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):2061-4. doi: 10.1016/j.bmcl.2013.02.008. Epub 2013 Feb 13.

12.

Heterobivalent ligands target cell-surface receptor combinations in vivo.

Xu L, Josan JS, Vagner J, Caplan MR, Hruby VJ, Mash EA, Lynch RM, Morse DL, Gillies RJ.

Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21295-300. doi: 10.1073/pnas.1211762109. Epub 2012 Dec 10.

13.

Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Tafreshi NK, Huang X, Moberg VE, Barkey NM, Sondak VK, Tian H, Morse DL, Vagner J.

Bioconjug Chem. 2012 Dec 19;23(12):2451-9. doi: 10.1021/bc300549s. Epub 2012 Nov 27.

14.

Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Huynh AS, Chung WJ, Cho HI, Moberg VE, Celis E, Morse DL, Vagner J.

J Med Chem. 2012 Nov 26;55(22):9751-62. doi: 10.1021/jm301002f. Epub 2012 Nov 8.

15.

A national case-control study identifies human socio-economic status and activities as risk factors for tick-borne encephalitis in Poland.

Stefanoff P, Rosinska M, Samuels S, White DJ, Morse DL, Randolph SE.

PLoS One. 2012;7(9):e45511. doi: 10.1371/journal.pone.0045511. Epub 2012 Sep 19.

16.

Occupational exposure to body fluids among health care workers in Georgia.

Butsashvili M, Kamkamidze G, Kajaia M, Morse DL, Triner W, Dehovitz J, McNutt LA.

Occup Med (Lond). 2012 Dec;62(8):620-6. doi: 10.1093/occmed/kqs121. Epub 2012 Aug 6.

17.

Photoacoustic tomography and fluorescence molecular tomography: a comparative study based on indocyanine green.

Wang B, Zhao Q, Barkey NM, Morse DL, Jiang H.

Med Phys. 2012 May;39(5):2512-7. doi: 10.1118/1.3700401.

18.

Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.

Tafreshi NK, Bui MM, Bishop K, Lloyd MC, Enkemann SA, Lopez AS, Abrahams D, Carter BW, Vagner J, Grobmyer SR, Gillies RJ, Morse DL.

Clin Cancer Res. 2012 Jan 1;18(1):207-19. doi: 10.1158/1078-0432.CCR-11-0238. Epub 2011 Oct 20. Erratum in: Clin Cancer Res. 2012 Mar 1;18(5):1483. Gobmyer, Stephen R [corrected to Grobmyer, Stephen R].

19.

Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Barkey NM, Tafreshi NK, Josan JS, De Silva CR, Sill KN, Hruby VJ, Gillies RJ, Morse DL, Vagner J.

J Med Chem. 2011 Dec 8;54(23):8078-84. doi: 10.1021/jm201226w. Epub 2011 Nov 10.

20.

A sucrose-derived scaffold for multimerization of bioactive peptides.

Rao V, Alleti R, Xu L, Tafreshi NK, Morse DL, Gillies RJ, Mash EA.

Bioorg Med Chem. 2011 Nov 1;19(21):6474-82. doi: 10.1016/j.bmc.2011.08.053. Epub 2011 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk